Thermo Fisher Scientific Receives Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Finesse Solutions,...
February 13 2017 - 09:15AM
Business Wire
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in
serving science, today announced that its pending acquisition of
Finesse Solutions, Inc., a leader in the development of scalable
control automation systems and software for bioproduction, has
received early termination of the waiting period under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
Thermo Fisher expects to complete the acquisition in the coming
days.
Based in Santa Clara, California, Finesse Solutions is a leader
in bioprocess management technology, generating approximately $50
million in revenue in 2016. Its proprietary Smart™ technology,
which consists of sensors, controllers and software, is designed to
optimize the bioproduction workflow. The business will be
integrated into Thermo Fisher’s Life Sciences Solutions Segment.
Terms of the transaction were not disclosed.
“Finesse Solutions has been a technology partner since 2013, and
we are pleased to add their complementary capabilities to our
leading bioproduction offering,” said Marc N. Casper, president and
chief executive officer of Thermo Fisher Scientific. “Finesse
Solutions has developed a universal control system that will
combine seamlessly with our existing single-use technologies to
strengthen our position in the high-growth bioproduction
market.”
“We are excited to join Thermo Fisher Scientific, and look
forward to leveraging the company’s strength and reach to
accelerate the development and commercialization of our Smart
technology platform,” added Dr. Barbara Paldus, CEO and co-founder
of Finesse Solutions.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE:TMO) is the world
leader in serving science, with revenues of $18
billion and more than 55,000 employees globally. Our mission
is to enable our customers to make the world healthier, cleaner and
safer. We help our customers accelerate life sciences research,
solve complex analytical challenges, improve patient diagnostics
and increase laboratory productivity. Through our premier brands –
Thermo Scientific, Applied Biosystems, Invitrogen, Fisher
Scientific and Unity Lab Services – we offer an unmatched
combination of innovative technologies, purchasing convenience and
comprehensive support. For more information, please visit
www.thermofisher.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170213005564/en/
Thermo Fisher ScientificMedia:Ron O’Brien,
781-622-1242ron.obrien@thermofisher.comwww.thermofisher.comorInvestors:Ken
Apicerno, 781-622-1294ken.apicerno@thermofisher.com
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2023 to Mar 2024